Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study.
J. Am. Coll. Cardiol., Feb;47(3 Suppl):S44-9 (2006)
Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors.
Pharmacotherapy., Mar;26(3):333-40 (2006)
CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).
Cytokine., Mar;33(5):258-63 (2006)
Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study.
Pharmacotherapy., Nov;26(11):1572-7 (2006)
Complementary and alternative medicine use among individuals participating in research: implications for research and practice.
Pharmacotherapy., Dec;26(12):1794-801 (2006)
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE).
Clin Cardiol., Feb;30(2):69-74 (2007)
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Circulation., Feb;109(6):722-5 (2004)
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.
J. Am. Coll. Cardiol., Jun;43(11):2009-14 (2004)
Commentary on "new and emerging theories of cardiovascular disease".
Biol Res Nurs., Jul;6(1):17-20; discussion 21-3 (2004)
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
JAMA., Sep;292(10):1179-87 (2004)
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).
Clin Cardiol., Jul;28(7):321-8 (2005)